Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.

Over 50 million Americans serve as unpaid caregivers for chronically ill loved ones, a role that can foster personal growth but also leads to caregiver distress—a mix of physiological, psychological, interpersonal, and spiritual impairments affecting 30-70% of caregivers. Existing treatments do not fully address all these components. Psychedelic-assisted psychotherapy (PAP) has shown promise in clinical trials for conditions overlapping with caregiver distress, such as anxiety, depression, suicidal ideation, and inflammation, while enhancing empathy, connectedness, and reducing existential distress. Although no studies have yet tested PAP for caregiver distress, this narrative review argues it could comprehensively treat all biopsychosocial-spiritual dimensions of the condition, outlining safety, psychedelic selection, and therapeutic structure for future research.

Study at a glance

Abstract

More than 50 million people in the United States serve as uncompensated informal caregivers to chronically ill friends or family members. Providing care to a sick loved one can contribute to personal growth but can also cause significant strain. Caregiver distress refers to a constellation of physiological, psychological, interpersonal, and spiritual impairments that typically result when an individual's own health becomes affected while caring for another. Caregiver distress is highly prevalent, affecting an estimated 30-70% of individuals across various caregiver populations. Although evidence-based treatments for caregiver distress exist, they do not sufficiently address all its components. In recent years, clinical trials have demonstrated that psychedelic-assisted psychotherapy (PAP) may have applications for treating a range of medical and psychiatric conditions that have significant overlap in symptoms to those seen in caregiver distress. While no studies to date have examined PAP for caregiver distress, this article provides a rationale for investigating PAP as a potential novel treatment for this indication. A narrative review on the effects and clinical applications of PAP that significantly overlap with the dimensions of caregiver distress was conducted. Safety considerations, psychedelic selection, and therapeutic structure for studying PAP in the treatment of caregiver distress were also examined. Psychologically, PAP has been shown to treat anxiety, depression, and reduce suicidal ideation. Physiologically, evidence suggests that psychedelics have anti-inflammatory properties, which may aid caregivers suffering from chronic inflammation. Interpersonally, PAP has been demonstrated to enhance feelings of empathy, connectedness, and strengthen social relationships, which can often become strained while caregiving. Spiritually, PAP has been shown to ameliorate existential distress and hopelessness in cancer patients, which may similarly benefit demoralized caregivers. PAP has the potential to comprehensively treat all biopsychosocial-spiritual dimensions of caregiver distress.